Related references
Note: Only part of the references are listed.IL-15 in the Combination Immunotherapy of Cancer
Thomas A. Waldmann et al.
FRONTIERS IN IMMUNOLOGY (2020)
Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
Karin M. Knudson et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Development of a recombinant human IL-15•sIL-15Rα/Fc superagonist with improved half-life and its antitumor activity alone or in combination with PD-1 blockade in mouse model
Meiqi Zhao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
IL15 by Continuous Intravenous Infusion to Adult Patients with Solid Tumors in a Phase I Trial Induced Dramatic NK-Cell Subset Expansion
Kevin C. Conlon et al.
CLINICAL CANCER RESEARCH (2019)
Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
Alexandra Berger et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Nano-pulse stimulation induces potent immune responses, eradicating local breast cancer while reducing distant metastases
Siqi Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
Checkpoint Inhibitors in the Treatment of Breast Cancer
Tomas G. Lyons et al.
CURRENT ONCOLOGY REPORTS (2018)
Immune Checkpoint Inhibitor Therapy in Breast Cancer
Cesar A. Santa-Maria et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Jeffrey S. Miller et al.
CLINICAL CANCER RESEARCH (2018)
Breast Cancer Immunotherapy: Facts and Hopes
Leisha A. Emens
CLINICAL CANCER RESEARCH (2018)
IL-12 Influence mTOR to Modulate CD8+ T Cells Differentiation through T-bet and Eomesodermin in Response to Invasive Pulmonary Aspergillosis
Hao Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2017)
IL-15 receptor alpha as the magic wand to boost the success of IL-15 antitumor therapies: The upswing of IL-15 transpresentation
Johan M. J. Van den Bergh et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Transcription Factor T-bet Orchestrates Lineage Development and Function in the Immune System
Axel Kallies et al.
TRENDS IN IMMUNOLOGY (2017)
Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
Azharuddin Sajid Syed Khaja et al.
ONCOTARGET (2017)
CD215+Myeloid Cells Respond to Interleukin 15 Stimulation and Promote Tumor Progression
Shouheng Lin et al.
FRONTIERS IN IMMUNOLOGY (2017)
Immunobiology of the IL-15/IL-15Rα complex as an antitumor and antiviral agent
Yin Guo et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2017)
IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas
Peter S. Kim et al.
ONCOTARGET (2016)
T-box Transcription Factors Combine with the Cytokines TGF-β and IL-15 to Control Tissue-Resident Memory T Cell Fate
Laura K. Mackay et al.
IMMUNITY (2015)
Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer
Kevin C. Conlon et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Molecular Pathways: Interleukin-15 Signaling in Health and in Cancer
Anjali Mishra et al.
CLINICAL CANCER RESEARCH (2014)
IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells
Fella Tamzalit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Electrotransfer of single-stranded or double-stranded DNA induces complete regression of palpable B16.F10 mouse melanomas
L. Heller et al.
CANCER GENE THERAPY (2013)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Characterization and Favorable in Vivo Properties of Heterodimeric Soluble IL-15•IL-15Rα Cytokine Compared to IL-15 Monomer
Elena Chertova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
CpG and Interleukin-15 Synergize to Enhance IFN-γ Production by Activated CD8+ T Cells
Dustin Cobb et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Myeloid Suppressor Cell Depletion Augments Antitumor Activity in Lung Cancer
Minu K. Srivastava et al.
PLOS ONE (2012)
IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood
Michael C. Sneller et al.
BLOOD (2011)
Radiofrequency thermal ablation of breast tumors combined with intralesional administration of IL-7 and IL-15 augments anti-tumor immune responses and inhibits tumor development and metastasis
Mehran Habibi et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy
C. Marcela Diaz-Montero et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells
Moses K. Donkor et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2009)
IL-15 Renders Conventional Lymphocytes Resistant to Suppressive Functions of Regulatory T Cells through Activation of the Phosphatidylinositol 3-Kinase Pathway
Melika Ben Ahmed et al.
JOURNAL OF IMMUNOLOGY (2009)
Imagable 4T1 model for the study of late stage breast cancer
Kai Tao et al.
BMC CANCER (2008)
Lnterleukin-15/interieukin-15Rα complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells
Mathieu Epardaud et al.
CANCER RESEARCH (2008)
Preassociation of IL-15 with IL-15Rα-IgG1-Fc enhances its activity on proliferation of NK and CD8+/CD44high T cells and its antitumor action
Sigrid Dubois et al.
JOURNAL OF IMMUNOLOGY (2008)
The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells
Thomas Y. Wuest et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Combined IL-15/IL-15Rα immunotherapy maximizes IL-15 activity in vivo
Thomas A. Stoklasek et al.
JOURNAL OF IMMUNOLOGY (2006)
Differential effects of IL-15 and IL-21 in myeloid (CD11b+) and lymphoid (CD11b-) bone marrow cells
Martin Pelletier et al.
JOURNAL OF IMMUNOLOGY (2006)
Emergence of immune escape variant of mammary tumors that has distinct proteomic profile and a reduced ability to induce danger signals
MH Manjili et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin
AM Intlekofer et al.
NATURE IMMUNOLOGY (2005)
Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance
H Kobayashi et al.
BLOOD (2005)
Coordinate expression and trans presentation of interleukin (IL)-15Rα and IL-15 supports natural killer cell and memory CD8+ T cell homeostasis
PR Burkett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Antigen-driven effector CD8 T cell function regulated by T-bet
BM Sullivan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
IL-15 promotes the survival of naive and memory phenotype CD8+ T cells
M Berard et al.
JOURNAL OF IMMUNOLOGY (2003)
Cutting edge:: Requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells
KS Schluns et al.
JOURNAL OF IMMUNOLOGY (2002)
Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure
T Yajima et al.
JOURNAL OF IMMUNOLOGY (2002)
Development of spontaneous airway changes consistent with human asthma in mice lacking T-bet
S Finotto et al.
SCIENCE (2002)
IL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
J Marks-Konczalik et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
